ANDA 84869, held by Sandoz. Imipramine Hydrochloride.
As of Nov 16, 2026, ANDA 84869 (Imipramine Hydrochloride), held by Sandoz, was first approved by FDA on Sep 16, 1994, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 16, 1994 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Imipramine Hydrochloride25MG · tablet;oral | Imipramine Hydrochloride | Discontinued |
| Apr 20, 1995 | Supplement 34Labeling | Approved | None posted |
| Sep 16, 1994 | Original application | Approved | None posted |
| Jun 25, 1993 | Supplement 33Labeling | Approved | None posted |
| Mar 12, 1993 | Supplement 32Labeling | Approved | None posted |
| Jul 31, 1992 | Supplement 31Labeling | Approved | None posted |
| Apr 26, 1989 | Supplement 23Labeling | Approved | None posted |
| Sep 9, 1986 | Supplement 18Manufacturing | Approved | None posted |
| Sep 9, 1986 | Supplement 19Manufacturing | Approved | None posted |
| Sep 9, 1986 | Supplement 20Manufacturing | Approved | None posted |
| Sep 9, 1986 | Supplement 21Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters